Last update :
31/03/2026
Various   Denosumab  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Bomyntra France
Jubbonti France
Jubereq France
Obodence France
Osenvelt France
Osvyrti France
Prolia Argentina, Australia, Belgium, Brazil, Canada, Chile, Croatia, Finland, Germany, Great Britain, Hungary, Ireland, Italy, Luxembourg, Malaysia, Mexico, Norway, Peru, Spain, Sweden, Switzerland, Turkey
Stoboclo France
Wyost France
Xbryk France
Xgeva Argentina, Australia, Belgium, Brazil, Canada, Chile, Croatia, Finland, France, Germany, Great Britain, Hungary, Ireland, Italy, Luxembourg, Malaysia, Mexico, Norway, Romania, Spain, Sweden, Switzerland, Turkey
Stability in solutions   injection   Stability in solutions : Denosumab     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass None 70 mg/mL 2-8°C Protect from light
1460 Day
5187
Manufacturer's stability data

Glass None 70 mg/mL 25°C Protect from light
60 Day
5187
Manufacturer's stability data


  Mentions Légales